Logo image of DPT.PA

S.T. DUPONT (DPT.PA) Stock Fundamental Analysis

EPA:DPT - Euronext Paris - Matif - FR0000054199 - Common Stock - Currency: EUR

0.1025  +0 (+0.2%)

Fundamental Rating

2

Taking everything into account, DPT scores 2 out of 10 in our fundamental rating. DPT was compared to 39 industry peers in the Textiles, Apparel & Luxury Goods industry. DPT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. DPT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DPT has reported negative net income.
In the past year DPT has reported a negative cash flow from operations.
DPT had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DPT reported negative operating cash flow in multiple years.
DPT.PA Yearly Net Income VS EBIT VS OCF VS FCFDPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

DPT's Return On Assets of -1.88% is on the low side compared to the rest of the industry. DPT is outperformed by 74.36% of its industry peers.
DPT has a worse Return On Equity (-4.08%) than 71.79% of its industry peers.
With a Return On Invested Capital value of 0.50%, DPT is not doing good in the industry: 79.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -1.88%
ROE -4.08%
ROIC 0.5%
ROA(3y)-7.16%
ROA(5y)-13.62%
ROE(3y)-107.46%
ROE(5y)-111.33%
ROIC(3y)N/A
ROIC(5y)N/A
DPT.PA Yearly ROA, ROE, ROICDPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

DPT has a worse Operating Margin (0.47%) than 79.49% of its industry peers.
In the last couple of years the Operating Margin of DPT has declined.
Looking at the Gross Margin, with a value of 55.91%, DPT is in line with its industry, outperforming 41.03% of the companies in the same industry.
DPT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.47%
PM (TTM) N/A
GM 55.91%
OM growth 3YN/A
OM growth 5Y-37.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.1%
GM growth 5Y-0.81%
DPT.PA Yearly Profit, Operating, Gross MarginsDPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DPT is destroying value.
The number of shares outstanding for DPT has been increased compared to 1 year ago.
The number of shares outstanding for DPT has been increased compared to 5 years ago.
Compared to 1 year ago, DPT has an improved debt to assets ratio.
DPT.PA Yearly Shares OutstandingDPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DPT.PA Yearly Total Debt VS Total AssetsDPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

DPT has an Altman-Z score of 3.10. This indicates that DPT is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.10, DPT is doing good in the industry, outperforming 61.54% of the companies in the same industry.
DPT has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DPT (0.30) is better than 74.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 3.1
ROIC/WACC0.06
WACC8.22%
DPT.PA Yearly LT Debt VS Equity VS FCFDPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.76 indicates that DPT should not have too much problems paying its short term obligations.
The Current ratio of DPT (1.76) is better than 71.79% of its industry peers.
A Quick Ratio of 1.02 indicates that DPT should not have too much problems paying its short term obligations.
DPT's Quick ratio of 1.02 is fine compared to the rest of the industry. DPT outperforms 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.02
DPT.PA Yearly Current Assets VS Current LiabilitesDPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for DPT have decreased strongly by -150.00% in the last year.
DPT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.82%.
Measured over the past years, DPT shows a decrease in Revenue. The Revenue has been decreasing by -0.22% on average per year.
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)6.82%
Revenue growth 3Y19.2%
Revenue growth 5Y-0.22%
Sales Q2Q%1.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DPT.PA Yearly Revenue VS EstimatesDPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
DPT.PA Price Earnings VS Forward Price EarningsDPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DPT is valued a bit more expensive than the industry average as 76.92% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 33.72
DPT.PA Per share dataDPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

S.T. DUPONT

EPA:DPT (5/8/2025, 7:00:00 PM)

0.1025

+0 (+0.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners90.6%
Ins Owner ChangeN/A
Market Cap96.73M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.8
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB 3.86
EV/EBITDA 33.72
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.06
BVpS0.03
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.88%
ROE -4.08%
ROCE 0.68%
ROIC 0.5%
ROICexc 0.59%
ROICexgc 0.61%
OM 0.47%
PM (TTM) N/A
GM 55.91%
FCFM N/A
ROA(3y)-7.16%
ROA(5y)-13.62%
ROE(3y)-107.46%
ROE(5y)-111.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-33.76%
ROICexc growth 3YN/A
ROICexc growth 5Y-31.48%
OM growth 3YN/A
OM growth 5Y-37.48%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.1%
GM growth 5Y-0.81%
F-Score4
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 2.57
Cap/Depr 89.25%
Cap/Sales 4.7%
Interest Coverage 0.16
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.76
Quick Ratio 1.02
Altman-Z 3.1
F-Score4
WACC8.22%
ROIC/WACC0.06
Cap/Depr(3y)125.52%
Cap/Depr(5y)84.1%
Cap/Sales(3y)6.59%
Cap/Sales(5y)5.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.82%
Revenue growth 3Y19.2%
Revenue growth 5Y-0.22%
Sales Q2Q%1.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y188.38%
EBIT growth 3YN/A
EBIT growth 5Y-37.61%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-264.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.55%
OCF growth 3YN/A
OCF growth 5YN/A